00465nas a2200157   4500000000100000000000100001008004100002100001500043700001400058700001200072700001400084700002900098245016400127300000900291490000700300       2017                            d1 aS. Langham1 aA. Wright1 aH. Shaw1 aS. Bryson1 aS. O\textquoterightLeary00aBudget impact analysis of oral glycopyrronium bromide (Sialanar\texttrademark) for the symptomatic treatment of severe sialorrhoea (Drooling) in the UK setting  aA7200 v20